The electrodes were utilized for determination of buspirone as a model pharmaceutical drug.
As a model pharmaceutical product, theophylline powders were prepared based on the standard formulation.
Both dry and wet powders of a model pharmaceutical formulation were studied to develop understanding of the influence of moisture content on the flow structure during granulation.
The effect of surface roughness (detrimental attribute) on the amount of powder sticking to a stainless steel surface for a model pharmaceutical material is also qualitatively determined.
Polyvinylpyrrolidone (PVP) – a model pharmaceutical binder – was spray-dried with varying l-leucine feed concentrations to create small surface-engineered binder particles with varying cohesion.
The aim of this study was to investigate the influence of the intrinsic inter-particulate cohesion of model pharmaceutical powders on their aerosolization from a dry powder inhaler.
Pervaporation experiments were conducted to recover 1-butanol from model pharmaceutical aqueous waste using a surface modified poly vinylidene difluoride) membrane.
This study investigates the use of co-melt fluidised bed granulation for the agglomeration of model pharmaceutical powders, namely, lactose mono-hydrate, PEG 10000, poly-vinyl pyrolidone and ibuprofen as a model drug.
The aim of this research was to investigate process and formulation parameters that affect FHMG, in a pharmaceutical context, using Lutrol® F68 (copolymer of polyoxyethylene-polyoxypropylene) as a meltable binder with inert glass ballotini acting as a model pharmaceutical powder.
